Atlas Trials

AION Healthspan, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch AION Healthspan, Inc.

RecordFirmDate
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) (NCT06721143)AION Healthspan, Inc.2025-01-23

Track AION Healthspan, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.